Evidence map›Paper›PMID 35044576›Full record

ArticleJournal of fluorescence2022

Pyridine-2-yl Quinoxaline (2-CPQ) Derivative As a Novel Pink Fluorophore: Synthesis, and Chemiluminescence Characteristics.

Zahra Hashemi, Mohammad Ali Ebrahimzadeh, Pourya Biparva, Seyed Mohammad Abedirad

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of fluorescence, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Zahra HashemiPharmaceutical Sciences Research Center, Department of Medicinal Chemistry, School of Pharmacy, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Mohammad Ali EbrahimzadehPharmaceutical Sciences Research Center, Department of Medicinal Chemistry, School of Pharmacy, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran. zadeh20@gmail.com.ORCID http://orcid.org/0000-0002-8769-9912
Pourya BiparvaDepartment of Basic Sciences, Sari University of Agricultural Sciences and Natural Resources, P.O.Box 578, Sari, Iran. pb.biparva@sanru.ac.ir.
Seyed Mohammad AbediradDepartment of Basic Sciences, Sari University of Agricultural Sciences and Natural Resources, P.O.Box 578, Sari, Iran.
Mazandaran University of Medical Sciences · IRSari Agricultural Sciences and Natural Resources University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Quinoxaline derivatives are well-known N-heterocycles with pharmacological and fluorescence activities. Almost all quinoxaline derivatives with extensive π-conjugation have been introduced as fluorophores which emit blue and green light. For the first time, we designed and synthesized 6-chloro-2,3 di(Pyridine-2yl) quinoxaline (2-CPQ) as a pink fluorophore in acetonitrile medium by simple route at room temperature whitin 30 min. The synthesized quinoxaline was identified using

Indexed as

ChemiluminescenceFluorophoresPink lightQuinoxaline derivative

Identifiers

PMID35044576
OpenAlexW4206657353

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.